Stock vs Stock Comparison

The Cooper Companies, Inc. vs AbbVie Inc.

ABBV wins the Tale of the Tape 6–3.

COO$60.34
ABBV$217.13

🏆 Tale of the Tape

36
COOABBV
9.2%Profitability (Net Margin)6.9%
30.5xValuation (P/E)106.2x
4.7%Efficiency (ROIC)8.3%
5/9Health (Piotroski F)7/9
3.5Safety (Altman Z)2.0
5.1%Growth (Rev YoY)8.6%
-0.23Risk (Sharpe 1Y)0.61
0.50xBalance Sheet (D/E)-42.50x
2.67%FCF Yield4.23%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.217
252-Day Correlation
0.211
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricCOOABBV
Market Cap$11.9B$384.7B
P/E Ratio30.5x106.2x
Forward P/E12.2x13.4x
P/B1.43x-57.80x
Dividend Yield3.18%
Beta0.890.30

Quantitative Metrics

MetricCOOABBV
DCF Fair Value$27.92$126.26
DCF Upside-61.1%-38.9%
Piotroski F5/97/9
Altman Z3.472.01
Beneish M-2.49-2.87
FCF Yield2.67%4.23%
Net Debt/EBITDA2.2x3.0x
ROIC4.7%8.3%
WACC10.3%7.4%
ROIC – WACC-5.7pp0.8pp
Gross Margin65.5%70.2%
Net Margin9.2%6.9%
Rev Growth YoY5.1%8.6%
Sharpe (1Y)-0.230.61
Max Drawdown 3Y
FCF Payout Ratio65%

COO Price

Loading chart...

ABBV Price

Loading chart...

ETF Exposure

COO found in:

XHE1.46%
VBR0.28%
XLV0.23%
VHT0.20%
RSP0.20%
VB0.16%
ONEV0.11%
SCHV0.06%
IWD0.05%
SPYV0.04%
VONV0.04%
ESGV0.03%
IVV0.03%
SCHX0.03%
SCHB0.02%
ITOT0.02%
SPLG0.02%
ONEO0.02%
VOO0.02%
SPY0.02%
URTH0.02%
SPTM0.02%
ACWI0.02%
QUS0.01%

ABBV found in:

XLV7.07%
IYH6.86%
VHT6.04%
HDV5.61%
SCHD3.53%
DGRO2.52%
DGRW1.99%
MGV1.85%
VIG1.68%
VYM1.56%
NOBL1.49%
VTV1.46%
SDY1.42%
IWF1.39%
SCHV1.38%
VONG1.21%
XBI1.09%
ESGV0.78%
SPYV0.71%
IVV0.69%
SPLG0.68%
SCHX0.66%
SCHB0.62%
ITOT0.61%
VOO0.60%
SPY0.59%
VONE0.57%
SPTM0.55%
VTI0.54%
SPYG0.50%
URTH0.48%
ACWI0.41%
VFVA0.41%
VT0.33%
QUS0.32%
VFMV0.25%
RSP0.19%
ONEO0.03%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

COO vs ABBV: Head-to-Head Analysis

The Cooper Companies, Inc. (COO) and AbbVie Inc. (ABBV) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABBV leads 6–3 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, COO generates a return on invested capital (ROIC) of 4.7% compared to ABBV's 8.3%. This suggests ABBV is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between COO and ABBV is 0.217, indicating low correlation, making them an effective diversification pair in a portfolio context.

COO appears in 24 ETFs tracked by SecuritiesDB, while ABBV appears in 38 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, COO or ABBV?

Our quantitative analysis compares COO and ABBV across nine fundamental dimensions. ABBV wins the Tale of the Tape 6–3. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are COO and ABBV correlated?

The 252-day correlation between COO and ABBV is 0.217. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.